The study analyzed nearly 120,000 hours of chronic intracranial recordings from 24 patients undergoing deep brain stimulation in the ventral capsule and ventral striatum for treatment-resistant obsessive-compulsive disorder. Before stimulation initiation, circadian neural features distinguished patients who responded to treatment from non-responders. Within the first two weeks of therapy, reduction in neural predictability differentiated responders from non-responders and correlated with the magnitude of subsequent symptom improvement months before stable clinical response was achieved. During chronic treatment, neural predictability tracked clinical response state. The findings establish a framework for neural biomarkers throughout the course of DBS therapy: forecasting treatment response before stimulation, detecting early therapeutic engagement after activation, and longitudinally monitoring clinical response.